Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 12, 2026
Performance of Prognostic Models in Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin After Platinum-Based Chemotherapy and Immune Checkpoint Inhibitors: YUSHIMA StudyHiroki Shimoda, Yuki Nakamura, Masaharu Inoue, et al.
Japanese Journal of Clinical Oncology|March 16, 2026
Lymph node metastasis as a favorable prognostic factor in metastatic urothelial carcinoma with histological variants treated with pembrolizumab: a retrospective multicentric study (YUSHIMA study-04)Ichiro Yonese, Fumitaka Koga, Masahiro Toide, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 22, 2025
Clinical Features and Risk Factors of Enfortumab Vedotin-Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study (YUSHIMA Study)Takahiko Soma, Hajime Tanaka, Yuki Nakamura, et al.
Japanese Journal of Clinical Oncology|January 28, 2026
Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysisShugo Yajima, Soichiro Yoshida, Wei Chen, et al.
The Prostate|March 19, 2026
Real-World Comparison of Triplet Versus Doublet Therapy in Japanese Patients With High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Propensity-Weighted Analysis From the YUSHIMA Registry and Exploratory Bayesian Evidence SynthesisYosuke Yasuda, Soichiro Yoshida, Shugo Yajima, et al.
BMJ Open|March 25, 2025
Add-on or switch to vibegron in patients with overactive bladder insufficiently responding to initial 4-week antimuscarinics: a randomised, parallel-group, multicentre trial (ADVISR) protocolTakanobu Yamamoto, Soichiro Yoshida, Yuya Maezawa, et al.
Plos Neglected Tropical Diseases|April 12, 2023
Genomic analysis of two phlebotomine sand fly vectors of Leishmania from the New and Old WorldFrédéric Labbé, Maha Abdeladhim, Jenica Abrudan, et al.
Pageof 3